For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Revance Therapeutics, Inc.

USPTO Granted Patents = 34

CIPO Patents = 51

EPO Patents = 16

Trademarks = 69

Forward Citations = 248

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Jacob M Waugh (26 out of 34 patents)

Michael D Dake (12 out of 34 patents)

Curtis L Ruegg (11 out of 18 patents)

4. Gary E Borodic (5 out of 31 patents)

5. Stewart A Thompson (4 out of 7 patents)

6. Hongran Fan Stone (4 out of 4 patents)

7. Martin Andrew Acquadro (1 out of 7 patents)

8. Jae Hoon Lee (1 out of 1 patent)

9. Sunita Babbar (1 out of 1 patent)

10. Alice Du (0 patent)

11. Hongran Fan Stone (0 patent)

12. Connie L Ho (0 patent)

13. Dan Browne (0 patent)

14. Hongran F Stone (0 patent)

15. Hongran F Stone (0 patent)

34 patents: Sort by Forward Citations

1. 12257293 - Methods of treatment for cervical dystonia (2025-03-25),

2. 12161703 - Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders (2024-12-10),

3. 11911449 - Albumin-free botulinum toxin formulations (2024-02-27),

4. 11484580 - Topical ocular preparation of botulinum toxin for use in ocular surface disease (2022-11-01),

5. 11471708 - Injectable botulinum toxin formulations (2022-10-18),

6. 11466262 - Methods and systems for purifying non-complexedneurotoxin (2022-10-11),

7. 11351232 - Albumin-free botulinum toxin formulations (2022-06-07),

8. 10857215 - Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds (2020-12-08),

9. 10744078 - Compositions and methods for topical application and transdermal delivery of botulinum toxins (2020-08-18),

10. 10441641 - Botulinum toxin and the treatment of primary disorders of mood and affect (2019-10-15),

11. 10201594 - Compositions and methods for safe treatment of rhinitis (2019-02-12),

12. 10172877 - Compositions and methods for topical diagnostic and therapeutic transport (2019-01-08),

13. 10111939 - Albumin-free botulinum toxin formulations (2018-10-30),

14. 10080786 - Methods for treating pain by topical application and transdermal delivery of botulinum toxin (2018-09-25),

15. 9956435 - Injectable botulinum toxin formulations (2018-05-01),

Revance Therapeutics is a biotechnology company focused on developing transformative therapies to treat aesthetic and therapeutic conditions. Their innovative technology platform and product candidates, including DaxibotulinumtoxinA for Injection, aim to revolutionize the field of dermatology and facial aesthetics. With a commitment to scientific excellence and patient satisfaction, Revance aims to improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#19 in Newark, CA

#2,298 in California

#9,663 in US

#19,027 in the World

Newark, CA, United States of America

Revance Therapeutics, Inc.

Forward Citations = 248

20 inventors:

Jacob M Waugh (26 out of 34 patents)

Michael D Dake (12 out of 34 patents)

Curtis L Ruegg (11 out of 18 patents)

4. Gary E Borodic (5 out of 31 patents)

5. Stewart A Thompson (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…